Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology
Link
http://link.springer.com/content/pdf/10.1186/s40164-019-0143-z.pdf
Reference74 articles.
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
2. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 2002;346(2):92–8.
3. Cafarotti S, Lococo F, Froesh P, Zappa F, Andre D. Target therapy in lung cancer. Adv Exp Med Biol. 2016;893:127–36.
4. Jing W, Li MM, Zhang Y, Teng FF, Han AQ, Kong L, Zhu H. PD-1/PD-L1 blockades in non-small-cell lung cancer therapy. OncoTargets Ther. 2016;9:489–502.
5. Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541(7637):321–30.
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring the predictive potential of programmed death ligand 1 expression in healthy organs and lymph nodes as measured by18F-BMS-986192 PET: pooled analysis of data from four solid tumor types;Journal for ImmunoTherapy of Cancer;2024-06
2. Copper homeostasis dysregulation in respiratory diseases: a review of current knowledge;Frontiers in Physiology;2024-05-31
3. Evaluation of Chelator-to-Antibody Ratio on Development of 89Zr-iPET Tracer for Imaging of PD-L1 Expression on Tumor;International Journal of Molecular Sciences;2023-12-05
4. Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?;Cancers;2023-08-26
5. Peptide G-Protein-Coupled Receptors and ErbB Receptor Tyrosine Kinases in Cancer;Biology;2023-07-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3